Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nathalie Le Bastard

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
Journal of the Neurological Sciences|September 6, 2012
The role of CSF biomarkers in the diagnostic work-up of mixed vascular-degenerative dementiaSebastiaan Engelborghs, Nathalie Le Bastard
Molecular Diagnosis & Therapy|June 1, 2012
The impact of cerebrospinal fluid biomarkers on the diagnosis of Alzheimer's diseaseSebastiaan Engelborghs, Nathalie Le Bastard
Clinical Chemistry|April 15, 2015
Importance and impact of preanalytical variables on Alzheimer disease biomarker concentrations in cerebrospinal fluidNathalie Le Bastard, Peter Paul De Deyn, Sebastiaan Engelborghs
Journal of Alzheimer'S Disease : JAD|April 28, 2010
Plasma amyloid-beta forms in Alzheimer's disease and non-Alzheimer's disease patientsNathalie Le Bastard, Judith Leurs, Walter Blomme, et al.
Neurochemical Research|May 21, 2011
Serum glutamine synthetase has no value as a diagnostic biomarker for Alzheimer's diseaseYannick Vermeiren, Nathalie Le Bastard, Christopher M Clark, et al.
Journal of Alzheimer'S Disease : JAD|September 1, 2012
Comparison of two analytical platforms for the clinical qualification of Alzheimer's disease biomarkers in pathologically-confirmed dementiaNathalie Le Bastard, Els Coart, Hugo Vanderstichele, et al.
Alzheimer'S Research & Therapy|March 8, 2024
Exploring the potential of fully automated LUMIPULSE G plasma assays for detecting Alzheimer's disease pathologyAnuschka Silva-Spínola, Maria João Leitão, Alicia Nadal, et al.
Neurochemistry International|August 22, 2009
No correlation between time-linked plasma and CSF Abeta levelsNathalie Le Bastard, Laetitia Aerts, Judith Leurs, et al.
Neurochemistry International|June 16, 2009
Improved discrimination of autopsy-confirmed Alzheimer's disease (AD) from non-AD dementias using CSF P-tau(181P)Karen Koopman, Nathalie Le Bastard, Jean-Jacques Martin, et al.
Neurobiology of Aging|January 20, 2009
Added diagnostic value of CSF biomarkers in differential dementia diagnosisNathalie Le Bastard, Jean-Jacques Martin, Eugeen Vanmechelen, et al.
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
Journal of the Neurological Sciences|September 6, 2012
The role of CSF biomarkers in the diagnostic work-up of mixed vascular-degenerative dementiaSebastiaan Engelborghs, Nathalie Le Bastard
Molecular Diagnosis & Therapy|June 1, 2012
The impact of cerebrospinal fluid biomarkers on the diagnosis of Alzheimer's diseaseSebastiaan Engelborghs, Nathalie Le Bastard
Clinical Chemistry|April 15, 2015
Importance and impact of preanalytical variables on Alzheimer disease biomarker concentrations in cerebrospinal fluidNathalie Le Bastard, Peter Paul De Deyn, Sebastiaan Engelborghs
Journal of Alzheimer'S Disease : JAD|April 28, 2010
Plasma amyloid-beta forms in Alzheimer's disease and non-Alzheimer's disease patientsNathalie Le Bastard, Judith Leurs, Walter Blomme, et al.
Neurochemical Research|May 21, 2011
Serum glutamine synthetase has no value as a diagnostic biomarker for Alzheimer's diseaseYannick Vermeiren, Nathalie Le Bastard, Christopher M Clark, et al.
Journal of Alzheimer'S Disease : JAD|September 1, 2012
Comparison of two analytical platforms for the clinical qualification of Alzheimer's disease biomarkers in pathologically-confirmed dementiaNathalie Le Bastard, Els Coart, Hugo Vanderstichele, et al.
Alzheimer'S Research & Therapy|March 8, 2024
Exploring the potential of fully automated LUMIPULSE G plasma assays for detecting Alzheimer's disease pathologyAnuschka Silva-Spínola, Maria João Leitão, Alicia Nadal, et al.
Neurochemistry International|August 22, 2009
No correlation between time-linked plasma and CSF Abeta levelsNathalie Le Bastard, Laetitia Aerts, Judith Leurs, et al.
Neurochemistry International|June 16, 2009
Improved discrimination of autopsy-confirmed Alzheimer's disease (AD) from non-AD dementias using CSF P-tau(181P)Karen Koopman, Nathalie Le Bastard, Jean-Jacques Martin, et al.
Neurobiology of Aging|January 20, 2009
Added diagnostic value of CSF biomarkers in differential dementia diagnosisNathalie Le Bastard, Jean-Jacques Martin, Eugeen Vanmechelen, et al.
Pageof 5